{"name":"Novo Nordisk","permalink":"novo-nordisk","crunchbase_url":"http://www.crunchbase.com/financial-organization/novo-nordisk","homepage_url":"","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"+45 4444 8888","description":"","email_address":"","number_of_employees":null,"founded_year":1922,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri Jun 19 00:33:12 UTC 2009","updated_at":"Sat Jun 20 03:19:38 UTC 2009","overview":"<p>Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.</p>","image":{"available_sizes":[[[70,49],"assets/images/resized/0004/9782/49782v1-max-150x150.png"],[[70,49],"assets/images/resized/0004/9782/49782v1-max-250x250.png"],[[70,49],"assets/images/resized/0004/9782/49782v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"Corporate Headquarters","address1":"Novo AllÃ©","address2":"","zip_code":"2880","city":"BagsvÃ¦rd","state_code":null,"country_code":"DNK","latitude":55.75323,"longitude":12.448555}],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Lars","last_name":"Rebien SÃ¸rensen","permalink":"lars-rebien-srensen","image":{"available_sizes":[[[140,127],"assets/images/resized/0004/9783/49783v1-max-150x150.jpg"],[[140,127],"assets/images/resized/0004/9783/49783v1-max-250x250.jpg"],[[140,127],"assets/images/resized/0004/9783/49783v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"CFO","person":{"first_name":"Jesper","last_name":"Brandgaard","permalink":"jesper-brandgaard","image":{"available_sizes":[[[140,127],"assets/images/resized/0004/9784/49784v1-max-150x150.jpg"],[[140,127],"assets/images/resized/0004/9784/49784v1-max-250x250.jpg"],[[140,127],"assets/images/resized/0004/9784/49784v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"COO","person":{"first_name":"KÃ¥re","last_name":"Schultz","permalink":"kre-schultz","image":{"available_sizes":[[[140,127],"assets/images/resized/0004/9785/49785v1-max-150x150.jpg"],[[140,127],"assets/images/resized/0004/9785/49785v1-max-250x250.jpg"],[[140,127],"assets/images/resized/0004/9785/49785v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"a","source_url":"http://www.ospreypharma.com/#investment","source_description":"Osprey Pharmaceuticals","raised_amount":11000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":5,"funded_day":1,"company":{"name":"Osprey Pharmaceuticals USA","permalink":"osprey-pharmaceuticals-usa","image":{"available_sizes":[[[150,16],"assets/images/resized/0004/9529/49529v1-max-150x150.jpg"],[[250,27],"assets/images/resized/0004/9529/49529v1-max-250x250.jpg"],[[450,50],"assets/images/resized/0004/9529/49529v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pieris-ag.com/316--~pieris_en~corporate_communications~recent_news~recent_news.html","source_description":"Pieris raises â‚¬ 25 M (US$ 38 M) in Series B financing round led by OrbiMed Advisors LLC","raised_amount":39470000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":null,"company":{"name":"PIERIS Proteolab","permalink":"pieris-proteolab","image":{"available_sizes":[[[150,104],"assets/images/resized/0004/9781/49781v1-max-150x150.png"],[[199,139],"assets/images/resized/0004/9781/49781v1-max-250x250.png"],[[199,139],"assets/images/resized/0004/9781/49781v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/affimed-raises-20m-fund-innovative-antibody-trials/2010-04-29","source_description":"Affimed raises â‚¬20M to fund innovative antibody trials","raised_amount":20000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":4,"funded_day":29,"company":{"name":"Affimed Therapeutics","permalink":"affimed-therapeutics","image":{"available_sizes":[[[150,41],"assets/images/resized/0008/6010/86010v1-max-150x150.png"],[[234,65],"assets/images/resized/0008/6010/86010v1-max-250x250.png"],[[234,65],"assets/images/resized/0008/6010/86010v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}